88
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Expression of DUSP4 Transcript Variants As A Potential Biomarker for Colorectal Cancer

, , ORCID Icon, , , & show all
Pages 639-650 | Received 21 Aug 2019, Accepted 08 Apr 2020, Published online: 02 Jul 2020

References

  • Haggar FA , BousheyRP. Colorectal cancer epidemiology: incidence, mortality, survival and risk factors. Clin. Colon Rectal Surg.22(4), 191–197 (2009).
  • Aran V , VictorinoAP, ThulerLC, FerreiraCG. Colorectal cancer: epidemiology disease mechanisms and interventions to reduce onset and mortality. Clin. Colorectal Cancer.15(3), 195–203 (2016).
  • Chandran SP , NatarajanSB, ChandraseharanS, MohdShahimi MSB. Nano drug delivery strategy of 5-fluorouracil for the treatment of colorectal cancer. J. Cancer Res. Pract.4(2), 45–48 (2017).
  • Tanaka T , TanakaM, TanakaT, IshigamoriR. Biomarkers for colorectal cancer. Int. J. Mol. Sci.11(9), 3209–3225 (2010).
  • Colussi D , BrandiG, BazzoliF, RicciardielloL. Molecular pathways involved in colorectal cancer: implications for disease behavior and prevention. Int. J. Mol. Sci.14(8), 16365–16385 (2013).
  • Pritchard CC , GradyWM. Colorectal cancer molecular biology moves into clinical practice. Gut60(1), 116–129 (2011).
  • Low HB , ZhangY. Regulatory roles of MAPK phosphatases in cancer. Immune Netw.16(2), 85–98 (2016).
  • Bermudez O , PagèsG, GimondCet al. The dual-specificity MAP kinase phosphatases: critical roles in development and cancer. Am. J. Physiol. Cell Physiol.299, C189–C202 (2013).
  • Nunes-Xavier C , Romá-MateoC, RíosPet al. Dual-specificity MAP kinase phosphatases as targets of cancer treatment. Anticancer Agents Med. Chem.11(1), 109–132 (2011).
  • Waha A , FelsbergJ, HartmannWet al. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. Cancer Res.70(4), 1689–1699 (2010).
  • Sloss CM , CadalbertL, FinnSG, FullerSJ, PlevinR. Disruption of two putative nuclear localization sequences is required for cytosolic localization of mitogen-activated protein kinase phosphatase-2. Cell. Signal.17(6), 709–716 (2005).
  • Sim J , YiK, KimHet al. Immunohistochemical expression of dual-specificity protein phosphatase 4 in patients with colorectal adenocarcinoma. Gastroenterol. Res. Pract.2015, 283764 (2015).
  • Wang Y , JiQ. DUSP4/MKP2 overexpression is associated with BRAF V600E mutation and aggressive behavior of papillary thyroid cancer. Onco Targets Ther.9, 2255–2263 (2016).
  • Lawan A , Al-HarthiS, CadalbertLet al. Deletion of the dual-specific phosphatase-4 (DUSP-4) gene reveals an essential non-redundant role for MAP kinase phosphatase-2 (MKP-2) in proliferation and cell survival. J. Biol. Chem.286(15), 12933–12943 (2011).
  • Chomczynski P , SacchiN. The single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem.162(1), 156–159 (1987).
  • Marshall OJ . PerlPrimer: cross-platform graphical primer design for standard, bisulphite and real-time PCR. Bioinformatics20, 2471–2472 (2004).
  • Schmittgen TD , LivakKJ. Analyzing real-time PCR data by the comparative CT method. Nat. Protoc.3(6), 1101–1108 (2008).
  • Krzystek-korpacka M , DiakowskaD, BaniaJ, GamianA. Expression stability of common housekeeping genes is differently affected by bowel inflammation and cancer: implications for finding suitable normalizers for inflammatory bowel disease studies. Inflamm. Bowel Dis.20(7), 1147–1156 (2014).
  • Sørby LA , AndersenSN, BukholmIRK, JacobsenMB. Evaluation of suitable reference genes for normalization of real-time reverse transcription PCR analysis in colon cancer. J. Exp. Clin. Cancer Res.29(1), 144 (2010).
  • Kheirelseid EAH , ChangKH, NewellJ, KerinMJ, MillerN. Identification of endogenous control genes for normalisation of real-time quantitative PCR data in colorectal cancer. BMC Mol. Biol.11, 12 (2010).
  • Pitule P , VycitalO, BruhaJANet al. Differential expression and prognostic role of selected genes in colorectal cancer patients. Anticancer Res.33, 4855–4865 (2013).
  • Owens DM , KeyseSM. Differential regulation of MAP kinase signalling by dual-specificity protein phosphatases. Oncogene26(22), 3203–3213 (2007).
  • Cadalbert LC , SlossCM, CunninghamMRet al. Differential regulation of MAP kinase activation by a novel splice variant of human MAP kinase phosphatase-2. Cell. Signal.22(3), 357–365 (2010).
  • Gröschl B , BettstetterM, GiedlCet al. Expression of the MAP kinase phosphatase DUSP4 is associated with microsatellite instability in colorectal cancer (CRC) and causes increased cell proliferation. Int. J. Cancer Expr.132(7), 1537–1546 (2013).
  • De Vriendt V , DeRoock W, FabioAet al. DUSP4 expression identifies a subset of colorectal cancer tumors that differ in MAPK activation, regardless of the genotype. Biomarkers18(6), 516–524 (2013).
  • Cagnol S , RivardN. Oncogenic KRAS and BRAF activation of the MEK/ERK signaling pathway promotes expression of dual-specificity phosphatase 4 (DUSP4/MKP2) resulting in nuclear ERK1/2 inhibition. Oncogene32(5), 564–576 (2013).
  • Ishihara S , WatanabeT, AkahaneTet al. Tumor location is a prognostic factor in poorly differentiated adenocarcinoma, mucinous adenocarcinoma and signet-ring cell carcinoma of the colon. Int. J. Colorectal Dis.27(3), 371–379 (2012).
  • Saigusa S , InoueY, TanakaKet al. Decreased expression of DUSP4 is associated with liver and lung metastases in colorectal cancer. Med. Oncol.30(3), 620–627 (2013).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.